Slow Capital, Inc. Amgen Inc Transaction History

Slow Capital, Inc.

$645 Million
Q3 2024

A detailed history of Slow Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Slow Capital, Inc. holds 12,841 shares of AMGN stock, worth $3.59 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

12,841

Previous 13,498 4.87%

Holding current value

$3.59 Million

Previous $4.22 Million 1.9%

% of portfolio

0.64%

Previous 0.68%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $203,262 - $221,658	-657 Reduced 4.87%	12,841 $4.14 Million
Q2 2024 Jul 24, 2024	SELL	$262.75 - $319.31 $259,597 - $315,478	-988 Reduced 6.82%	13,498 $4.22 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $23,391 - $28,236	-87 Reduced 0.6%	14,486 $4.12 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $43,724 - $49,326	-171 Reduced 1.16%	14,573 $4.2 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $172,952 - $214,724	791 Added 5.67%	14,744 $3.96 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $68,137 - $80,571	-318 Reduced 2.23%	13,953 $3.1 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $477,997 - $582,598	2,117 Added 17.42%	14,271 $3.45 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $72,602 - $92,250	317 Added 2.68%	12,154 $3.19 Million
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $43,096 - $48,604	-192 Reduced 1.6%	11,837 $2.67 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $101,281 - $112,708	439 Added 3.79%	12,029 $2.93 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $21,927 - $24,257	-100 Reduced 0.86%	11,590 $2.8 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $1.16 Million - $1.33 Million	-5,847 Reduced 33.34%	11,690 $2.63 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $77,903 - $91,272	367 Added 2.14%	17,537 $3.73 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $525,321 - $582,805	2,249 Added 15.07%	17,170 $4.19 Million
Q1 2021 May 20, 2021	BUY	$221.91 - $258.6 $92,980 - $108,353	419 Added 2.89%	14,921 $3.71 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $463,569 - $540,215	2,089 Added 16.83%	14,502 $3.61 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $23,369 - $27,828	-108 Reduced 0.86%	12,413 $2.85 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $68,283 - $75,936	291 Added 2.38%	12,521 $3.18 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $11,275 - $13,836	57 Added 0.47%	12,230 $2.89 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $209,758 - $278,196	-1,151 Reduced 8.64%	12,173 $2.47 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $59,033 - $75,878	-312 Reduced 2.29%	13,324 $3.21 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $28,379 - $34,005	-163 Reduced 1.18%	13,636 $2.64 Million
Q2 2019 Aug 01, 2019	BUY	$166.7 - $195.41 $9,668 - $11,333	58 Added 0.42%	13,799 $2.54 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $25,321 - $28,543	140 Added 1.03%	13,741 $2.61 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $95,800 - $111,830	537 Added 4.11%	13,601 $2.65 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $62,813 - $70,813	339 Added 2.66%	13,064 $2.71 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $634,311 - $712,468	3,820 Added 42.9%	12,725 $2.35 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $2.97 Million - $3.47 Million	-17,540 Reduced 66.33%	8,905 $1.52 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $4.46 Million - $4.99 Million	26,445	26,445 $4.6 Million

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.

Account